● Recruiting

Travoprost Intraocular Implant + iStent Infinite

Condition: Glaucoma, Open-Angle · Sponsor: Glaukos Corporation

PhasePhase 4

Planned participants150

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

Adult subjects with elevated intraocular pressure will be randomized to receive iStent infinite trabecular bypass system plus a travoprost intraocular implant or receive a sham procedure plus a travoprost intraocular implant and be followed for 12 months.

This description comes directly from the study's public registry record.

Talk to the study team

Study Director · 949-739-8749 · idoseclinical@glaukos.com

Study Manager · 949-739-8749 · idoseclinical@glaukos.com

Always discuss trial participation with your own doctor first.

Locations (1)

Glaukos Clinical Study Site

Oklahoma City, Oklahoma, United States

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06066645